drugset / Press release
Emergent BioSolutions and MorphoSys Initiate Phase 1 Clinical Study to Evaluate the Novel Oncology Immunotherapeutic MOR209/ES414 for Prostate Cancer
2015-03-09 · Emergent BioSolutions · original emergentbiosolutions.com ↗
030915 - MOR209 ES414 Phase 1 Initiation MOR Reviewed FINAL.pdf 266.2 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗